Clinical trial

Optimum Treatment for Drug-Resistant Hypertension

NCT02369081

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2009-05-01

PhasePHASE4

Study timeline

Study start (unknown)2009-05-01Date precision: month

Registry last updated2015-07-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertension, Resistant to Conventional Therapyunresolved

Interventions

SpironolactoneDRUG · verified · RxNorm: spironolactone

BisoprololDRUG · verified · RxNorm: bisoprolol

DoxazosinDRUG · verified · RxNorm: doxazosin

PlaceboDRUG

Sponsors & collaborators

University of Cambridgelead sponsor

British Heart Foundationcollaborator

Mapped research locations

LondonUnited Kingdom3 BirminghamUnited Kingdom2 ManchesterUnited Kingdom1 GlasgowUnited Kingdom1 CambridgeUnited Kingdom1 EdinburghUnited Kingdom1 LeicesterUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02369081 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.